Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial
Insulin needs decrease rapidly upon initiation of semaglutide use in type 1 diabetes on pump therapy, predominantly due to bolus changes from less carbohydrate consumption. While diabetes technology helps to reduce hypoglycemia, adjustments to pump dosing are still required.
Authors
- Ahmad Haidar (ORCID: https://orcid.org/0000-0002-6700-0385)
- Melissa‐Rosina Pasqua (ORCID: https://orcid.org/0000-0003-2389-9066)
- Michael A. Tsoukas (ORCID: https://orcid.org/0000-0002-8326-7274)
Institutions
- McGill University Health Centre (CA)
- McGill University (CA)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1111/dom.70213
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00